Lindbrook Capital’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $5.58K | Buy |
154
+75
| +95% | +$2.72K | ﹤0.01% | 1907 |
|
|
2024
Q4 | $3.32K | Sell |
79
-78
| -50% | -$3.28K | ﹤0.01% | 2138 |
|
|
2024
Q3 | $8.72K | Buy |
157
+78
| +99% | +$4.33K | ﹤0.01% | 1745 |
|
|
2024
Q2 | $3.25K | Sell |
79
-38
| -32% | -$1.56K | ﹤0.01% | 2184 |
|
|
2024
Q1 | $5.46K | Buy |
117
+18
| +18% | +$840 | ﹤0.01% | 1858 |
|
|
2023
Q4 | $4.73K | Buy |
99
+14
| +16% | +$669 | ﹤0.01% | 1916 |
|
|
2023
Q3 | $3.03K | Sell |
85
-135
| -61% | -$4.81K | ﹤0.01% | 1979 |
|
|
2023
Q2 | $10.1K | Buy |
220
+28
| +15% | +$1.29K | ﹤0.01% | 1459 |
|
|
2023
Q1 | $7.7K | Sell |
192
-248
| -56% | -$9.95K | ﹤0.01% | 1623 |
|
|
2022
Q4 | $20.4K | Buy |
440
+326
| +286% | +$15.1K | ﹤0.01% | 1053 |
|
|
2022
Q3 | $5K | Buy |
+114
| New | +$5K | ﹤0.01% | 1686 |
|
|
2022
Q2 | – | Sell |
-28
| Closed | -$2K | – | 2739 |
|
|
2022
Q1 | $2K | Buy |
28
+4
| +17% | +$286 | ﹤0.01% | 2058 |
|
|
2021
Q4 | $2K | Buy |
+24
| New | +$2K | ﹤0.01% | 1813 |
|
|
2021
Q2 | – | Sell |
-7
| Closed | -$1K | – | 1994 |
|
|
2021
Q1 | $1K | Buy |
+7
| New | +$1K | ﹤0.01% | 1769 |
|
|
2020
Q1 | – | Sell |
-17
| Closed | -$1K | – | 1847 |
|
|
2019
Q4 | $1K | Sell |
17
-70
| -80% | -$4.12K | ﹤0.01% | 1427 |
|
|
2019
Q3 | $4K | Buy |
87
+24
| +38% | +$1.1K | ﹤0.01% | 1117 |
|
|
2019
Q2 | $4K | Hold |
63
| – | – | ﹤0.01% | 1119 |
|
|
2019
Q1 | $4K | Hold |
63
| – | – | ﹤0.01% | 1130 |
|
|
2018
Q4 | $2K | Buy |
+63
| New | +$2K | ﹤0.01% | 1197 |
|